Technology Commercialization
Drug Valuation: V+IP
(Valuation + IP Guarantee)
- Program Objective
- To support the commercialization and financing of innovative drug development projects through professional drug valuation and technology finance programs provided by the Korea Technology Finance Corporation (KIBO).
- Program Details
- Program Duration: Up to 3 months per project (For the detailed schedule, please refer to the recruitment announcement.)
- Scope of Support:
① Drug Valuation: Drug valuation report based on the proprietary valuation methodologies of the Korea Technology Finance Corporation (KIBO)
② Valuation + IP Guarantee: IP-backed credit guarantee of up to KRW 4 billion
③ Guarantee-Linked Investment: Investment linkage opportunity of up to KRW 3 billion per company
④ Pre-Diagnostic Assessment: Preliminary assessment and advisory support based on the KOSDAQ technology listing evaluation framework
- Contact
Business Development Team: kddf_bd@kddf.org